CRENESSITY Trademark

Trademark Overview


On Wednesday, January 29, 2025, a trademark application was filed for CRENESSITY with the United States Patent and Trademark Office. The USPTO has given the CRENESSITY trademark a serial number of 99021889. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, May 6, 2026. This trademark is owned by Neurocrine Biosciences, Inc.. The CRENESSITY trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing medical information; Providing medical information to patients and medical professionals in the field of congenital adrenal hyperplasia

Providing medical research information; providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia
crenessity

General Information


Serial Number99021889
Word MarkCRENESSITY
Filing DateWednesday, January 29, 2025
Status730 - FIRST EXTENSION - GRANTED
Status DateWednesday, May 6, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 9, 2025

Trademark Statements


Description of MarkThe mark consists of four lines with curved top and bottom edges that become progressively larger from left to right and form the overall shape of a conical seashell. The lines appear in dark purple, purple, dark orange, orange from left to right and are positioned above the word "CRENESSITY" appearing in dark blue.
Goods and ServicesProviding medical information; Providing medical information to patients and medical professionals in the field of congenital adrenal hyperplasia
Indication of Colors claimedThe color(s) dark purple, purple, dark orange, orange, and dark blue is/are claimed as a feature of the mark.
Goods and ServicesProviding medical research information; providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 29, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 29, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeurocrine Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
US

Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
US

Trademark Events


Event DateEvent Description
Wednesday, January 29, 2025NEW APPLICATION ENTERED
Wednesday, January 29, 2025APPLICATION FILING RECEIPT MAILED
Thursday, March 20, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 20, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 20, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 22, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 22, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, June 4, 2025ASSIGNED TO EXAMINER
Monday, June 9, 2025PRIORITY ACTION WRITTEN
Monday, June 9, 2025PRIORITY ACTION E-MAILED
Monday, June 9, 2025NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, July 10, 2025TEAS REQUEST TO DIVIDE RECEIVED
Thursday, July 10, 2025TEAS AMENDMENT OF USE RECEIVED
Friday, July 18, 2025ASSIGNED TO LIE
Monday, July 21, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 10, 2025DIVISIONAL REQUEST RECEIVED
Wednesday, July 23, 2025DIVISIONAL PROCESSING COMPLETE
Friday, August 1, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 1, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 1, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 11, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 3, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 9, 2025PUBLISHED FOR OPPOSITION
Tuesday, September 9, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 4, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 4, 2026SOU TEAS EXTENSION RECEIVED
Sunday, May 3, 2026SOU EXTENSION 1 FILED
Wednesday, May 6, 2026SOU EXTENSION 1 GRANTED
Wednesday, May 6, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED